Nathalie Lambot graduated as pharmacist from the Free University of Brussels, and has a PhD in Biomedical Sciences.
After having worked several years in CRO and pharmaceutical company in international regulatory affairs, Nathalie has joined 2013 pharma.be, the Belgian association of innovative (bio)pharmaceutical industry, where she works as advisor in Public Health.
The national competent authorities of Belgium and Luxembourg share their views about the e-PIL Pilot
A: Iris Geussens: Digitalisation is the future, and the pharmaceutical sector cannot stay behind. The advantage of an electronic package leaflet is that you always have access to the most up-to-date information. Most changes to a patient information leaflet have to do with the safety of the product. When ...
The e-PIL Pilot was set-up in Belgium and Luxembourg with the objective to demonstrate the equivalence between the paper patient information leaflet and the electronic patient information leaflet in providing information on the safe and effective use of medicines in hospital setting. The first results of the Pilot are promising ...